Hello. Sign in to personalize your visit. New user? Register now.  
Human Gene Therapy
Scalable Purification of Adeno-Associated Virus Type 2, 4, or 5 Using Ion-Exchange Chromatography

To cite this article:
Nikola Kaludov, Beverly Handelman, John A. Chiorini. Human Gene Therapy. July 2002, 13(10): 1235-1243. doi:10.1089/104303402320139014.

Full Text: • PDF for printing (374.5 KB) • PDF w/ links (309.1 KB)


Nikola Kaludov
Gene Therapy and Therapeutics Branch, National Institute of Dental and Cranialfacial Research, National Institutes of Health, Bethesda, MD 20892.
Beverly Handelman
Gene Therapy and Therapeutics Branch, National Institute of Dental and Cranialfacial Research, National Institutes of Health, Bethesda, MD 20892.
John A. Chiorini
Gene Therapy and Therapeutics Branch, National Institute of Dental and Cranialfacial Research, National Institutes of Health, Bethesda, MD 20892.

The availability of high-titer, high-purity, adeno-associated virus type 2 (AAV2) stocks has dramatically increased our understanding of this virus and its utility as a gene transfer vector. Current methods of purification take advantage of the stable interaction of AAV2 with heparin sulfate. This affinity chromatography, however, is not useful for purifying AAV4 and AAV5, because these serotypes lack heparin-binding activity. We have developed simple ion exchange high-performance liquid chromatography (HPLC) method for purifying different AAV serotypes that does not rely on the affinity of the viruses for heparin. The protocol is fast, efficient, and yields highly infectious material. Analysis of the highly purified virus indicated that more than 90% of the particles contained genomes and were more active than virus purified by cesium chloride (CsCl) gradient purification. This procedure is scalable and can easily be streamlined for large-scale production of recombinant adeno-associated virus (rAAV), regardless of the serotype. Ultimately, the new purification method will further the characterization of rAAV of different serotypes as vectors for gene therapy applications.

Free first page

This paper was cited by:

A Simplified Baculovirus-AAV Expression Vector System Coupled With One-step Affinity Purification Yields High-titer rAAV Stocks From Insect Cells
Richard H Smith, Justin R Levy, Robert M Kotin
Molecular Therapy. Jul 2009
CrossRef
Long-term transduction of miniature pig parotid glands using serotype 2 adeno-associated viral vectors
Bo Hai, Xing Yan, Antonis Voutetakis, Changyu Zheng, Ana P. Cotrim, Zhaochen Shan, Gang Ding, Chunmei Zhang, Junji Xu, Corinne M. Goldsmith, Sandra Afione, John A. Chiorini, Bruce J. Baum, Songlin Wang
The Journal of Gene Medicine. Jul 2009, Vol. 11, No. 6: 506-514
CrossRef
Scalable purification of AAV1 and AAV8 vectors using dual ion-exchange adsorptive membranes
Takashi Okada, Mutsuko Nonaka-Sarukawa, Ryosuke Uchibori, Kazue Kinoshita, Hiromi Hayashita-Kinoh, Yuko Nitahara-Kasahara, Shin'ichi Takeda, Keiya Ozawa
Human Gene Therapy. , Vol. 0, No. ja
Abstract | Full Text PDF
Tailoring the AAV vector capsid for gene therapy
L H Vandenberghe, J M Wilson, G Gao
Gene Therapy. Apr 2009, Vol. 16, No. 3: 311-319
CrossRef
Transduction of Nonhuman Primate Brain with Adeno-Associated Virus Serotype 1: Vector Trafficking and Immune Response
Piotr Hadaczek, John Forsayeth, Hanna Mirek, Keith Munson, John Bringas, Phil Pivirotto, Jodi L McBride, Beverly L. Davidson, Krystof S. Bankiewicz
Human Gene Therapy. Mar 2009, Vol. 20, No. 3: 225-237
Abstract | Full Text PDF | Reprints & Permissions
Transduction of non-human primate brain with adeno-associated virus serotype 1: vector trafficking and immune response
Piotr Hadaczek, John Forsayeth, Hanna Mirek, Keith Munson, John Bringas, Philip Pivirotto, Jodi McBride, Beverly Davidson, Krystof Bankiewicz
Human Gene Therapy. Jan 2009, Vol. 0, No. ja: 081212071307053
CrossRef
Coordinated control of connexin 26 and connexin 30 at the regulatory and functional level in the inner ear
S. Ortolano, G. Di Pasquale, G. Crispino, F. Anselmi, F. Mammano, J. A. Chiorini
Proceedings of the National Academy of Sciences. Jan 2009, Vol. 105, No. 48: 18776-18781
CrossRef
Molecular Engineering of Viral Gene Delivery Vehicles
David V. Schaffer, James T. Koerber, Kwang-il Lim
Annual Review of Biomedical Engineering. Sep 2008, Vol. 10, No. 1: 169-194
CrossRef
Strategies for manufacturing recombinant adeno-associated virus vectors for gene therapy applications exploiting baculovirus technology
A. Negrete, R. M. Kotin
Briefings in Functional Genomics and Proteomics. Jul 2008, Vol. 7, No. 4: 303-311
CrossRef
Toward exascale production of recombinant adeno-associated virus for gene transfer applications
S Cecchini, A Negrete, R M Kotin
Gene Therapy. Jul 2008, Vol. 15, No. 11: 823-830
CrossRef
Manufacturing and characterizing AAV-based vectors for use in clinical studies
J F Wright
Gene Therapy. Jul 2008, Vol. 15, No. 11: 840-848
CrossRef
Engineering Adeno-Associated Virus for One-Step Purification via Immobilized Metal Affinity Chromatography
James T. Koerber, Jae-Hyung Jang, Julie H. Yu, Ravi S. Kane, David V. Schaffer
Human Gene Therapy. Apr 2007, Vol. 18, No. 4: 367-378
Abstract | Full Text PDF | Reprints & Permissions
The use of recombinant adeno-associated virus for skeletal gene therapy
Juan Dai, A. Bakr M. Rabie
Orthodontics & Craniofacial Research. Mar 2007, Vol. 10, No. 1: 1-14
CrossRef
Adeno-Associated Virus Serotype 2-Mediated Gene Transfer to The Parotid Glands of Nonhuman Primates
Antonis Voutetakis, Changyu Zheng, Fumi Mineshiba, Ana P. Cotrim, Corinne M. Goldsmith, Michael Schmidt, Sandra Afione, Nienke Roescher, Mark Metzger, Michael A. Eckhaus, John A. Chiorini, Cynthia E. Dunbar, Robert E. Donahue, Bruce J. Baum
Human Gene Therapy. Feb 2007, Vol. 18, No. 2: 142-150
Abstract | Full Text PDF | Reprints & Permissions
Long-term persistence of gene expression from adeno-associated virus serotype 5 in the mouse airways
S G Sumner-Jones, L A Davies, A Varathalingam, D R Gill, S C Hyde
Gene Therapy. Jan 2007, Vol. 13, No. 24: 1703-1713
CrossRef
Production and characterization of adeno-associated viral vectors
Joshua C Grieger, Vivian W Choi, R Jude Samulski
Nature Protocols. Dec 2006, Vol. 1, No. 3: 1412-1428
CrossRef
Re-engineering Primary Epithelial Cells from Rhesus Monkey Parotid Glands for Use in Developing an Artificial Salivary Gland
Simon D. Tran, Takayuki Sugito, Giovanni Dipasquale, Ana P. Cotrim, Bidhan C. Bandyopadhyay, Kathryn Riddle, David Mooney, Marc R. Kok, John A. Chiorini, Bruce J. Baum
Tissue Engineering. Oct 2006, Vol. 0, No. 0: 060928130622002
CrossRef
Re-engineering Primary Epithelial Cells from Rhesus Monkey Parotid Glands for Use in Developing an Artificial Salivary Gland
Simon D. Tran, Takayuki Sugito, Giovanni Dipasquale, Ana P. Cotrim, Bidhan C. Bandyopadhyay, Kathryn Riddle, David Mooney, Marc R. Kok, John A. Chiorini, Bruce J. Baum
Tissue Engineering. Oct 2006, Vol. 12, No. 10: 2939-2948
Abstract | Full Text PDF | Reprints & Permissions
Mosaic vectors comprised of modified AAV1 capsid proteins for efficient vector purification and targeting to vascular endothelial cells
M D Stachler, J S Bartlett
Gene Therapy. Mar 2006
CrossRef
Current issues in adeno-associated viral vector production
O-W Merten, C Gény-Fiamma, A M Douar
Gene Therapy. Nov 2005, Vol. 12: S51-S61
CrossRef
Chromatographic purification of recombinant adenoviral and adeno-associated viral vectors: methods and implications
E Burova, E Ioffe
Gene Therapy. Nov 2005, Vol. 12: S5-S17
CrossRef
Recombinant Adeno-Associated Viral Vectors in the Nervous System
Corinna Burger, Kevin Nash, Ronald J. Mandel
Human Gene Therapy. Jul 2005, Vol. 0, No. 0: 050701034702015
CrossRef
Recombinant Adeno-Associated Viral Vectors in the Nervous System
Corinna Burger, Kevin Nash, Ronald J. Mandel
Human Gene Therapy. Jul 2005, Vol. 16, No. 7: 781-791
Abstract | Full Text PDF | Reprints & Permissions
Production of Recombinant Adeno-Associated Virus Vectors
S. Zolotukhin
Human Gene Therapy. May 2005, Vol. 16, No. 5: 551-557
Abstract | Full Text PDF | Reprints & Permissions
Infection Efficiency of Human and Mouse Embryonic Stem Cells Using Adenoviral and Adeno-Associated Viral Vectors
Joseph R. Smith-Arica, Alison J. Thomson, Ray Ansell, John Chiorini, Beverly Davidson, Jim McWhir
Cloning and Stem Cells. Mar 2003, Vol. 5, No. 1: 51-62
Abstract | Full Text PDF | Reprints & Permissions
All articles
Previous Next